Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Debica – page 2

18 clinical trials in Debica, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Debica at a glance
18
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

18 trials in Debica

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Regn7508
  • Sponsor:Regeneron Pharmaceuticals Inc.

Sjogren's syndrome

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen - Cilag International
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Debica

What the registry says about research in the country

01 Immunology & Infectious Disease Prevention

Innovative research focusing on the HPV vaccine administration in young populations, examining extended dosing regimens to prevent anogenital infections and related diseases.

  • HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58
  • Immunogenicity Studies
  • Pediatric Vaccination

Research explores optimal timing between vaccine doses in children aged 9-14 years compared to standard regimens in young adults.

02 Rheumatology

Clinical investigation of sonelokimab, a novel subcutaneous treatment for adults with active psoriatic arthritis who haven't previously received biological DMARDs.

  • Autoimmune Conditions
  • Joint Disease
  • Biologic Therapy

The research evaluates different dosing schedules to determine optimal therapeutic efficacy for inflammatory joint disease.

03 Cardiology

Groundbreaking study examining the combination of vicadrostat with empagliflozin for treating heart failure, specifically in patients with preserved ejection fraction.

  • Cardiovascular Disease
  • Combination Therapy
  • Heart Function

Research focuses on preventing cardiovascular death and reducing hospitalization rates in heart failure patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.